Program EuroValve 2017

January 26 -27, 2017 Crowne Plaza

Barcelona, SPAIN

www.eurovalvecongress.com

COURSE DIRECTORS Patrizio Lancellotti, Liege, Belgium Khalil Fattouch, Palermo, Italy Gilbert Habib, Marseille, France JosĂŠ Luis Zamorano, Madrid, Spain Luc A. Pierard, Liege, Belgium

Edito Welcome to EuroValve 2017!

It is a great pleasure to welcome you for this fifth edition in Barcelona, which offers you an exciting cultural, artistic and social scene at sensible prices.

As you may know, we always intend to favour more interactivity and discussions, especially thanks to several symposia, industry symposia, controversies and round tables.

Again, over 2 days, we will present an extensive program dedicated to valvular heart disease, focusing on genetics, surgery, epidemiology, transcatheter valve replacement, echocardiography and new imaging.

This year, we are hosting the ePosters presentation on Thursday January 26 in the plenary room.

Take your time to visit the exhibition and discover the Industry news as it is only thanks to their precious help that we could achieve our ambitious program. Do not miss Abbott Vascular, Boston Scientific and Siemens symposia in the plenary room.

We are very pleased to have you during two convivial days of fruitful teaching in Barcelona.

Enjoy the congress!

The course directors Patrizio Lancellotti, Khalil Fattouch, Gilbert Habib, José Luis Zamorano and Luc A. Pierard

EuroValve congress 2017 is endorsed by the

and the ESC Working Group on Valvular Heart Diseases

Programme Chairs Patrizio Lancellotti, Khalil Fattouch, Gilbert Habib, José Luis Zamorano, Luc A Piérard

International advisors Philippe Pibarot, Thomas Modine, Gilles Dreyfus, Maurice Sarano, Prakash P. Punjabi

Local Hosts Arturo Evangelista, Pilar Tornos

Faculty Walid Abukhudair, Feddah, Saudi Arabia Ottavio Alfieri, Milan, Italy Jean-François Avierino, Marseille, France Jutta Bergler-Klein, Vienna, Austria Anne Bernard, Tour, France Alain Berrebi, Paris, France John Chambers, London, United-Kingdom Bernard Cosyns, Braine-L’Alleud, Belgium Michele De Bonis, Milano, Italy Erwan Donal, Rennes, France Gilles Dreyfus, Monaco Raluca Elena Dulgheru, Brussels, Belgium Rodolphe Durieux, Liege, Belgium Arturo Evangelista, Barcelona, Spain Alain Fraisse, London, United-Kingdom Madalina Garbi, London, United-Kingdom Mattia Glauber, Milan, Italy Alexandra Gonçalvez, Porto, Portugal Ariana Gonzalez-Gómez, Madrid. Spain Bernard Iung, Paris, France Joëlle Kefer, Brussels, Belgium

Philippe Kolh, Liege, Belgium Giovanni La Canna, Milan, Italy Francesco Maisano, Zurich, Zwitzerland Christophe Martinez, Liège, Belgium Thomas Modine, Lille, France Jean-Luc Monin, Créteil, France Francesco Musumeci, Rome, Italy Maria Nazarena Pizzi, Barcelona, Spain Cécile Oury, Liege, Belgium Alessandro Parolari, Milan, Italy Agnes Pasquet, Brussels, Belgium Philippe Pibarot, Quebec, Canada Bernard Prendergast, Oxford, United-Kingdom Prakash P. Punjabi, London, United Kingdom Raphael Rosenhek, Vienna, Austria Maurice Sarano, Rochester, USA Shantanu Sengupta, New-Dehli, India Didier Tchétché, Toulouse, France Pilar Tornos, Barcelona, Spain Philippe Unger, Brussels, Belgium

Synoptic THURSDAY JANUARY 26

FRIDAYJANUARY 27

08:15 Welcome coffee in the exhibition hall

08:30

08:45 Opening ceremony

Welcome coffee in the exhibition hall

Patrizio Lancellotti, Khalil Fattouch, Gilbert Habib, José Luis Zamorano, Luc A Piérard

09:00 Symposium: optimizing outcomes in valvular heart disease

09:00 Case-based session: infective endocarditis. Applying the new guidelines

Pilar Tornos, Bernard Prendergast

09:55 Keynote lecture

Bernard Cosyns, Pilar Tornos

09:50 Flash news in mitral regurgitation

Patrizio Lancellotti, Jose Luis Zamonaro

10:15 10:45

Francesco Maisano, Jutta Bergler-Klein

Coffee break ePoster Competition 10:20 in the exhibition hall in the plenary room 10:50 Trends in cardiac surgery: joint with the Italian Society of Cardiac Surgery SICCH Alessandro Parolari, Luc A. Piérard

12:00

Transcatheter mitral interventions: concepts applications, imaging and outcomes. Joint with the Mitral Academy Patrizio Lancellotti, khalil Fattouch, Ottavio Alfieri

12:05 symposium

12:45

Coffee break in the exhibition hall

Lunch break in the exhibition hall

13:45

symposium

12:50

Lunch break in the exhibition hall

13:50 symposium

Flash news on pulmonary valve Prakash P. Punjabi, Philippe Unger

14:30 Ascending aorta dilation and aortic valve disease

14:50 Interactive session: what is your diagnosis?

Gilles Dreyfus, Khalil Fattouch

15:45

Flash news

Pilar Tornos, Michele De Bonis

15:50 Closing remarks

Arturo Evangelista, Madalina Garbi

16:15

Coffee break ePoster Competition in the exhibition hall in the plenary room 16:00

Patrizio Lancellotti, Khalil Fattouch, Gilbert Habib, José Luis Zamorano, Luc Piérard, Arturo Evangelista, Pilar Tornos

Adjournment

16:45 Short communications: hot topics in TAVI Patrizio Lancellotti, Khalil Fattouch

18:15

Short communications: how to manage anticoagulant therapy in valve disease: joint with the Heart Valve Society Gilbert Habib, Alain Berrebi

18:55

End of the sessions

www.eurovalvecongress.com

Thursday January 26, 2017 08:15

Welcome coffee in the exhibition hall

08:45 Opening ceremony Patrizio Lancellotti, Khalil Fattouch, Gilbert Habib, José Luis Zamorano, Luc A. Piérard 08:50 Local host presentation of Barcelona Arturo Evangelista, Pilar Tornos 09:00 Symposium: optimizing outcomes in valvular heart disease

Chairmen: Pilar Tornos, Bernard Prendergast 09:00 Heart valve center of reference, John Chambers 09:18 Endocarditis team, Gilbert Habib 09:36 Round table discussion with expert’s panel, Philippe Pibarot, Raphael Rosenhek, Anne Bernard, Walid Abukhudair 09:55 Keynote lecture

Chairmen: Patrizio Lancellotti, José Luis Zamonaro 09:55 Tricuspid regurgitation: prevalence and treatment approach, Maurice Sarano 10:05 Round table discussion with expert’s panel, Gilles Dreyfus, Alain Berrebi, Michele De Bonis 10:15 Coffee break sponsorized by ePosters competition in the plenary room Chairmen: Cécile Oury, Thomas Modine

in the exhibition hall

10:45 Trends in cardiac surgery: joint with the Italian Society of Cardiac Surgery SICCH

Chairmen: Alessandro Parolari, Luc A. Piérard 10:45 Is there a room for innovation in aortic surgery? Khalil Fattouch 11:00 Importance of the prosthesis choice in the valve-in-valve Era, Thomas Modine 11:15 Medium-low risk patients with AS: conventional, sutureless or TAVI? Francesco Musumeci 11:30 Cost-effectiveness of TAVI versus suturless in low-medium risk patients, Mattia Glauber 11:45 Round table discussion with expert’s panel, Erwan Donal, Thomas Modine, Rodolphe Durieux, Khalil Fattouch 12:00 symposium: Valves are to flow as Flow is to Valves 12:00 Multimodality imaging using fluoroscopy and full Volume 3D TEE in advanced valve therapy, Pierre-Yves Litzler 12:20 Echocardiographic innovations for transcatheter mitral valve procedures, Andrea Colli 12:40 Discussion 12:45

Lunch break in the exhibition hall

13:45

13:45 13:50 14:05 14:20

symposium: Shaping the future of TAVI Chairmen: Thomas Modine, Patrizio Lancellotti Introduction, Thomas Modine My clinical experience with Lotus, Didier Tchétché Expanding indications with TAVI, what does it take? Thomas Modine Wrap up, Patrizio Lancellotti

14:30 Ascending aorta dilation and aortic valve disease

Chairmen: Gilles Dreyfus, Khalil Fattouch 14:30 Mechanisms and progression, Agnes Pasquet 14:45 Ideal follow-up by imaging techniques, Arturo Evangelista 15:00 Risk in special circumstances: pregnancy, sport activities, Bernard Iung 15:15 Surgical indications. A critical point of view, Jean Luc Monin 15:30 Round table discussion with expert’s panel, Prakash P. Punjabi, Raluca Elena Dulgheru 15:45

15:45 16:00

Flash news Chairmen: Arturo Evangelista, Madalina Garbi HAVEC registry in aortic stenosis, Patrizio Lancellotti The role of imaging in clinical trials, Alexandra Gonçalvez

16:15 Coffee break in the exhibition hall ePosters competition in the plenary room

Chairmen: Jutta Bergler-Klein, José Luis Zamorano 16:45 Short communications: hot topics in TAVI

Chairman: Patrizio Lancellotti, Khalil Fattouch 16:45 Paravalvular regurgitation: did we fix it or is this still an issue in 2016?

Philippe Pibarot 17:00 Subclinical valve thrombosis post TAVR: should we panic or calm down?

Joëlle Kefer 17:15 TAVR is ready from prime time in intermediate risk population? low risk population? Didier Tchétché 17:30 TAVI durability: similar or worse than surgical valve, Thomas Modine 17:45 Does LV mechanics play a role in durability, José Luis Zamorano 18:00 Round table discussion with expert’s panel, Philippe Kolh, Bernard Prendergast, Luc A. Piérard, Christophe Martinez 18:15 Short communications: how to manage anticoagulant therapy in valve disease. Joint with the Heart Valve Society

Chairmen: Gilbert Habib, Alain Berrebi 18:15 After valve replacement, Raphael Rosenhek 18:25 In infective endocarditis, Pilar Tornos 18:35 Before and during pregnancy, Bernard Prendegast 18:45 Is there a place for new anticoagulants in prosthetic valves? Erwan Donal 18:55

End of the sessions

Friday January 27, 2017 08:30

Welcome coffee in the exhibition hall

09:00

09:00 09:20 09:40

Case-based session: infective endocarditis. Applying the new guidelines Chairmen: Bernard Cosyns, Pilar Tornos A case of large vegetation with neurological complication, Maria Nazarena Pizzi A case of prosthetic valve endocarditis, Ariana Gonzalez-Gomez Endocarditis in the elderly, Gilbert Habib

09:50 Flash news in mitral regurgitation

Chairmen: Francesco Maisano, Jutta Bergler-Klein 09:50 Mitral valve prolapse and sudden death, Jean-François Avierinos 10:05 Mitral valve pathology and treatment in hypertrophic cardiomyopathy, Gilles Dreyfus 10:20

Coffee break in the exhibition hall

10:50 Transcatheter mitral interventions: concepts applications, imaging and outcomes. Joint with the Mitral Academy

Chairmen: Patrizio Lancellotti, khalil Fattouch, Ottavio Alfieri 10:50 Clinical indications, Didier Tchéché 11:05 New imaging features in guiding therapeutic orientations, Giovanni La Canna 11:20 TMVR: early clinical outcomes, Thomas Modine 11:35 Percutaneous repair experiences? Francesco Maisano 11:50 Round discussion with expert’s panel, Luc A. Piérard, Didier Tchétché, Giovanni La Canna, Rodolphe Durieux, Madalina Garbi, Shantanu Sengupta 12:05 symposium: The present and the future of TMVR

Chairmen: Francesco Maisano, Magnus Settergren 1 2:05 Introduction Francesco Maisano, Magnus Settergren 12:07 Who can benefit now from the TMVR Therapy?

The Echo Perspective, Marta Sitges 12:17 Who can benefit now from the TMVR Therapy?

The Clinical Perspective, Dabit Arzamendi 12:27 Why to refer now to TMVR Therapy? Fausto Castriota 12:37 The future of TMVR Therapy, Magnus Settergren 12:47 Conclusions, Francesco Maisano 12:50

Lunch break in the exhibition hall

13:50 Flash news on pulmonary valve

Chairmen: Prakash P. Punjabi, Philippe Unger 13:50 Imaging assessment, Alain Fraisse 14:05 Indications for treatment, Agnes Pasquet 14:20 Treatment option, Alain Fraisse 14:35 Round discussion with experts panel, Michele De Bonis 14:50 Interactive session: what is your diagnosis?

Chairmen: Pilar Tornos, Michele De Bonis 14:50 A storm, Giovanni La Canna 15:05 A trick, Erwan Donal 15:20 A nightmare, Raluca Elena Dulgheru 15:35 A pitfall, Anne Bernard 15:50 Closing remarks Patrizio Lancellotti, Khalil Fattouch, Gilbert Habib, JosĂŠ Luis Zamorano, Luc PiĂŠrard, Arturo Evangelista, Pilar Tornos 16:00 Adjournment

www.eurovalvecongress.com

ePosters - First session 10:15 Combined tilting disc and bileaflet mechanical valves features, a possible solution for better hemodynamic performance Nima Mirkhani1, Mohammad Reza Davoudi2*, Pedram Hanafizadeh1,

Niloofar Saffarian3, Daryoosh Javidi4

1. University of Tehran, Tehran, Iran, Islamic Republic of 2. Katholieke Universiteit Leuven, Leuven, Belgium 3. Cardiovascular Department, Pars Hospital, Tehran, Iran, Islamic Republic of 4. Department of Cardiac Surgery, Pars Hospital, Tehran, Iran, Islamic Republic of

10:19 Impact of mitral regurgitation in coronary artery bypass Jennifer Estrada, Eduardo Bucio, Martha Garcia

Instituto Nacional de Cardiología Ignacio Chavez, ciudad de Mexico, Mexico

10:27

TAVI without a guidewire: eliminating risk for left ventricular rupture Jacek Baranowski, Andah Edemanwan, Henrik Ahn

University Hospital in Linköping, Linköping, Sweden

10:31 Inferior Patch Plasty normalizes tethering in ischemic mitral regurgitation inferior aneurysm/dyskinesia cases

Matteo Pettinari1, Gabriele Tamagnini1, Nicola Testa1, Philippe Bertrand2,

Roger Devotini1, Christiaan Van Kerrebroeck1, Robert Dion1, Herbert Guteramann1

1. Cardiac Surgery Department, Ziekenhuis Oost Limburg, Genk, Belgium 2. Cardiology Department, Ziekenhuis Oost Limburg, Genk, Belgium

10:35 Does aortic valve area < 1 cm² by Doppler echocardiography define adequately severe aortic stenosis?

Guillem Casas Masnou, Laura Galian, Teresa Gonzalez, Gisela Teixidó,

Laura Gutierrez, Giuliana Maldonado, Jose Rodriguez, Artur Evangelista

Hospital Vall Hebron, Barcelona, Spain

10:39 Impact of mitral valve repair on cardiac remodeling: results of conventional sternotomy and minimally invasive mitral valve surgery

Lorena Herrador, Daniel Pereda, Eduard Quintana, Manuel Castellà,

Ana García Álvarez, Bárbara Vidal, Silvia Montserrat, Susanna Prat,

Marta Sitges

Hospital Clínic, Barcelona, Spain

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ePosters - Second session 16:15 Hemodynamic performance of Mechanical Heart Valve Prosthesis For Different Adults Periods: Influence On Blood Flow Distribution In The Thoracic Aorta

Ghazaleh Hayati1, Nima Mirkhani1, Mohammad Reza Davoudi2,

Pedram Hanafizadeh1, Niloofar Saffarian3, Daryoosh Javidi4

1. University of Tehran, Tehran, Iran, Islamic Republic of

2. Katholieke Universiteit Leuven, Leuven, Belgium 3. Cardiovascular Department, Pars Hospital, Tehran, Iran, Islamic Republic of 4. Department of Cardiac Surgery, Pars Hospital, Tehran, Iran, Islamic Republic of

16:19 The importance of being “not transplantable”: A case report

Rossana Taravella, Giuseppe Cirrincione, Massimo Benedetto, Giuliana Pace,

Renato Ciofalo, Salvatore Asciutto, Marco Caruso

Arnas Civico, Cardiology UTIC, University of Palermo, Palermo, Italy 16:23 The affection of trans-valvular gradient on patient outcome in cases of sever aortic stenosis with impaired left ventricular function

Ihab Moursi, karim Al Fakharany

Zagazig University Hospital- Faculty of Human Medicine, Zagazig, Egypt 16:27 Aortic valve replacement with concomitant moderate mitral regurgitation: double valve replacement, risk or benefit?

Martha Garcia, Eduardo Bucio, Jennifer Estrada

Instituto Nacional de cardiologicía « Ignacio Chávez », México, Mexico 16:31 Effect of patient prosthesis mismatch in mitral position on pulmonary hypertension

Ganesh Kumar K Ammannaya

Lokmanya Tilak Municipal Medical College, Mumbai, India 16:35 Prognosis of maternal valvular heart disease,and foetal outcomes

Soundouss Ballali1, Kamal Belkadi2, Anass Assaidi1, Rachida Habbal1,

Ihssane Moussaid2, Said Salmi2

1. Cardiology department, IBN ROCHD hospital university, Casablanca, Morocco

2. Obstetric intensive unit care lalla meriem , Casablanca, Morocco

16:39

Surgery of infective endocarditis: about 223 patients.

Redha Lakehal, Radouane Boukharoucha, Abdelmalek Brahami

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Ehs El Riadh, Constantine, Algeria

Information Congress venue: CROWNE PLAZA BARCELONA FIRA CENTER Avenida Rius i Taulet 1-3 08004 Barcelona Spain Tel. +34 93 2289915 REGISTRATION DESK OPENING HOURS Thursday January 26 Friday January 27

07.45 - 19.30 08.00 - 17.00

EVENT COORDINATORS’ CONTACTS Project manager Stéphanie Meyer + 33 646 10 48 26 Managing director Vérane Bergeron Moreau + 33 621 78 87 16 Faculty, registration Margaux Gabrielli + 33 646 10 48 26 ORGANIZATION: divine [id] agency • Stéphanie Meyer: smeyer@divine-id.com • Mob. +33 (0) 646 10 48 26 •V érane Bergeron Moreau: vbergeron@divine-id.com • 17, rue Venture - 13001 Marseille, France • Tel. +33 (0) 491 57 19 60 • Fax +33 (0) 491 57 19 61 • www.divine-id.com

www.eurovalvecongress.com

Exhibition hall 3

Registration desk

ePosters

2

4

BUFFET

Exhibition hall

1

AUDITORIUM Preview room

5 Screen

Cloakroom

Booth Company 1 2 3 4 5

St. Jude Medical Abbott Vascular Livanova Medtronic GE Healthcare

EXHIBITION HOURS Thursday January 26 08.00 - 17.00 Friday January 27 08.15 - 14.00

ACKNOWLEDGEMENTS 2017

A Century of Improving Lives

Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical products to address diversified, unmet medical needs of patients in both mature and emerging markets.

With over 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 17,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people.

In addition to its strong portfolio of medicines for hypertension, dyslipidemia, bacterial infections, and thrombotic disorders, the Group’s research and development is focused on bringing forth novel therapies in cardiovascular-metabolic diseases, pain management, and oncology, including biologics.

For more information, please visit: WWW.DAIICHI-SANKYO.EU